Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 4/20 | 0.61 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.39 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.39 |
| ▸ | MMP12 | P39900 | 4/20 | 0.38 |
| ▸ | MMP13 | P45452 | 4/20 | 0.38 |
| ▸ | MMP2 | P08253 | 1/20 | 0.38 |
| ▸ | MMP9 | P14780 | 1/20 | 0.38 |
| ▸ | MMP14 | P50281 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | ACACB | O00763 | 1/20 | 0.35 |
| ▸ | ACACA | Q13085 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL447590 | 1.00 | GPR84 (0.61) | GPR84SLC22A6MAPTGABRR1LMNA | |
| SCHEMBL15518119 | 1.00 | GPR84 (0.61) | GPR84SLC22A6MAPTGABRR1LMNA | |
| SCHEMBL23528833 | 0.93 | GPR84 (0.70) | GPR84SLC22A6MAPTGABRR1LMNA | |
| SCHEMBL21552704 | 0.93 | GPR84 (0.70) | GPR84SLC22A6MAPTGABRR1LMNA | |
| SCHEMBL4759399 | 0.93 | GPR84 (0.70) | GPR84SLC22A6MAPTGABRR1LMNA | |
| SCHEMBL28922166 | 0.88 | GPR84 (0.67) | GPR84SLC22A6MAPTGABRR1LMNA | |
| SCHEMBL4749028 | 0.86 | GPR84 (0.61) | GPR84SLC22A6MAPTGABRR1LMNA | |
| SCHEMBL667381 | 0.86 | GPR84 (0.61) | GPR84SLC22A6MAPTGABRR1LMNA | |
| SCHEMBL16600523 | 0.86 | SLC22A6 (0.57) | GPR84SLC22A6MAPTGABRR1LMNA | |
| SCHEMBL27623054 | 0.84 | SLC22A6 (0.55) | GPR84SLC22A6MAPTGABRR1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260108442-A1 | COMPOUND FOR USE IN PROTECTING SKIN | TDELTAS LTD (GB) | 2026-04-23 | — | — | US | claimed |
| EP-4714505-A2 | COMPOUND FOR USE IN PROTECTING SKIN | Tdeltas Limited (GB) | 2026-03-25 | — | — | EP | claimed |
| US-11571479-B2 | Nutritional composition | TDELTAS (GB) | 2023-02-07 | — | — | US | claimed |
| US-20210015730-A1 | COMPOUND FOR USE IN PROTECTING SKIN | GOVERNMENT OF THE USA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF OF HEALTH AND HUMAN SERVICES | 2021-01-21 | — | — | US | claimed |
| US-20200360517-A1 | NUTRITIONAL COMPOSITION | TDELTAS (GB) | 2020-11-19 | — | — | US | claimed |
| US-10660958-B2 | Nutritional composition | TDELTAS LIMITED (GB) | 2020-05-26 | — | — | US | claimed |
| EP-2968091-A1 | COMPOUND FOR USE IN PROTECTING SKIN | Tdeltas Limited (GB) | 2016-01-20 | — | — | EP | claimed |
| WO-2014139599-A1 | COMPOUND FOR USE IN PROTECTING SKIN | TDELTAS LIMITED (GB) | 2014-09-18 | — | — | WO | claimed |
| US-20130102663-A1 | NUTRITIONAL COMPOSITION | TDELTAS LIMITED (GB) | 2013-04-25 | — | — | US | claimed |
| EP-2539312-A1 | NUTRITIONAL COMPOSITION | Tdeltas Limited (GB) | 2013-01-02 | — | — | EP | claimed |
| WO-2011101171-A1 | NUTRITIONAL COMPOSITION | TDELTAS LIMITED (GB) | 2011-08-25 | — | — | WO | claimed |
| US-20250275986-A1 | COMBINATION OF A KETONE BODY OR KETOGENIC COMPOUND WITH AN ANALGESIC OR ANTIOXIDANT | KETOSWISS AG (CH) | 2025-09-04 | — | — | US | disclosed |
| US-20250008999-A1 | Ketone Precursors And Methods Therefor | VDF FUTURECEUTICALS, INC. (US) | 2025-01-09 | — | — | US | disclosed |
| CN-118201608-A | Ketone precursors and methods thereof | VDF未来制剂股份有限公司 | 2024-06-14 | — | — | CN | disclosed |
| EP-4373483-A1 | COMBINATION OF A KETONE BODY OR KETOGENIC COMPOUND WITH AN ANALGESIC OR ANTIOXIDANT | KetoSwiss AG (CH) | 2024-05-29 | — | — | EP | disclosed |
| US-20140072654-A1 | CANCER WITH METABOLIC THERAPY AND HYPERBARIC OXYGEN | SAVIND, INC. (US) | 2014-03-13 | — | — | US | disclosed |
| WO-2013150153-A1 | KETONE BODIES AND KETONE BODY ESTERS FOR MAINTAINING OR IMPROVING MUSCLE POWER OUTPUT | TDELTAS LIMITED (GB) | 2013-10-10 | — | — | WO | disclosed |
| US-20130102663-A1 | NUTRITIONAL COMPOSITION | TDELTAS LIMITED (GB) | 2013-04-25 | — | — | US | disclosed |
| EP-2539312-A1 | NUTRITIONAL COMPOSITION | Tdeltas Limited (GB) | 2013-01-02 | — | — | EP | disclosed |
| WO-2011101171-A1 | NUTRITIONAL COMPOSITION | TDELTAS LIMITED (GB) | 2011-08-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260108442-A1 | COMPOUND FOR USE IN PROTECTING SKIN | CUTA, POT1, CETP | GPR84 3418/4885SLC22A6 2338/4885MAPT 552/4885 |
| US-20250275986-A1 | COMBINATION OF A KETONE BODY OR KETOGENIC COMPOUND WITH AN ANALGESIC OR ANTIOXIDANT | PKM, KCNMA1, KCNK18 | GPR84 977/4885SLC22A6 1496/4885MAPT 2350/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.